Abstract
Background: Transcatheter aortic valve replacement (TAVR) can lead to atrioventricular (AV) conduction changes and need for permanent pacemaker (PPM) implantation. There is currently no consensus on clinical decision making for PPM evaluation in patients undergoing TAVR.